ArticleEClinicalMedicine2025

Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial.

Jhingook Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.